Table 1 Summary of baseline characteristics and treatment parameters of patients with diabetic macular edema treated with subthreshold micropulse laser monotherapy
From: Real-life outcomes of subthreshold laser therapy for diabetic macular edema
| Age (years), mean ± SD | 64.8 ± 7.8 |
| Women % | 38.8 |
| Pseudophakic % | 17.8 |
| NPDR % | 44.6 |
| Previous panphotocoagulation % | 32.1 |
| Previous macular laser % | 21.4 |
| Intraretinal fluid % | 96.4 |
| Subretinal fluid % | 41.1 |
| Ellipsoid disruption % | 57.1 |
| Follow-up (weeks), mean ± SD | 14.1 ± 6.3 |
| BCVA logMAR, mean ± SD | 0.59 ± 0.32 |
| Laser power (mW) mean ± SD | 555 ± 150.7 |
| Number of spots (n), mean ± SD | 1,109.7 ± 580.4 |
| Retreatment % | 17.8 |